Racial Disparities in Pulse Oximeter Device Inaccuracy and Estimated Clinical Impact on COVID-19 Treatment Course

, American Journal of Epidemiology, 2022 Sep 29

Investigators

Kristen Azar, R.N., BSN, MSN/MPH, Investigator, Sylvia Sudat, PhD

Abstract

Arterial blood oxygen saturation measured by pulse oximetry (SpO2) may be differentially less accurate for people with darker skin pigmentation, which could potentially affect COVID-19 treatment course. We analyzed pulse oximeter accuracy and association with COVID-19 treatment outcomes using electronic health record (EHR) data from Sutter Health, a large, mixed-payer, integrated healthcare delivery system in northern California, United States (US). We analyzed two cohorts: (1) 43,753 concurrent arterial blood gas (ABG) oxygen saturation (SaO2)/SpO2 measurement pairs taken January 2020-February 2021 for Non-Hispanic white (NHW) or Non-Hispanic Black/African American (NHB) adults, and (2) 8,735 adults who went to the emergency department (ED) with COVID-19 July 2020-February 2021. Pulse oximetry systematically overestimated blood oxygenation by 1% more in NHB individuals than in NHW individuals. For people with COVID-19, this was associated with lower admission probability (-3.1 percentage-points), dexamethasone treatment (-3.1 percentage-points), and supplemental oxygen treatment (-4.5 percentage-points), as well as increased time-to-treatment: +37.2 minutes before dexamethasone initiation and +278.5 minutes before initiation of supplemental oxygen. These results call for additional investigation of pulse oximeters, and suggest that current guidelines for development, testing, and calibration of these devices should be revisited, investigated, and revised..

Pubmed Abstract

Pubmed AbstractOpens New Window

Associated Topics

Related Publications

Using variable importance measures from causal inference to rank risk factors of schistosomiasis infection in a rural setting in China.

Sudat SE, Carlton EJ, Seto EY, Spear RC, Hubbard AE.
Epidemiol Perspect Innov. 7:3. doi: 10.1186/1742-5573-7-3.
2010 Jul 14

Predicting all-cause risk of 30-day hospital readmission using artificial neural networks.

Jamei M, Nisnevich A, Wetchler E, Sudat S, Liu E.
PLoS One. 12(7):e0181173. doi: 10.1371/journal.pone.0181173. eCollection 2017.
2017 Jul 14

Predicting need for advanced illness or palliative care in a primary care population using electronic health record data.

Jung K, Sudat SEK, Kwon N, Stewart WF, Shan NH.
J Biomed Inform. 92:103115.
2019 Apr 01

Causal inference and prediction in health studies: environmental exposures and schistosomiasis, HIV-1 genotypic susceptibility scores and virologic suppression, and risk of hospital readmission for heart failure patients.

Sudat, S.
UC Berkeley. ProQuest ID: Sudat_berkeley_0028E_12729. Merritt ID: ark:/13030/m5xw4pw5. Retrieved from https://escholarship.org/uc/item/9z03362s
2012 Jun 01

A comparison of two worlds: How does Bayes hold up to the status quo for the analysis of clinical trials?

Pressman AR, Avins AL, Hubbard A, Satariano WA.
Contemp Clin Trials. 32(4):561-8. doi: 10.1016/j.cct.2011.03.010. Epub 2011 Mar 29.
2011 Jul 01